US5981197AExpiredUtility
Monoclonal antibody, hybridoma, their production and use thereof
Assignee: TAKEDA CHEMICAL INDUSTRIES LTDPriority: Feb 24, 1987Filed: Feb 23, 1998Granted: Nov 9, 1999
Est. expiryFeb 24, 2007(expired)· nominal 20-yr term from priority
A61K 38/00C07K 2319/02C07K 16/22C07K 14/503C07K 2319/00C07K 14/55
31
PatentIndex Score
1
Cited by
29
References
2
Claims
Abstract
A monoclonal antibody is produced from a cloned hybridoma, and the monoclonal antibody combines specifically with basic fibroblast growth factor (bFGF). Therefore, the monoclonal antibody can be advantageously used for assay reagents on bFGF or for purification of bFGF.
Claims
exact text as granted — not AI-modifiedWhat we claim is:
1. A method for detecting or measuring basic fibroblast growth factor (bFGF), which comprises using, as antibody, a monoclonal antibody which combines specifically with bFGF and has the characteristics: (a) it has molecular weight of about 140 to 160 kilodaltons, (b) it does not cross-react with acidic fibroblast growth factor, (c) it belongs to the immunoglobulin class IgM or IgG, and (d) it is capable of detecting human bFGF in a concentration of at least 0.5 ng/ml of bFGF by E/A method.
2. The method as claimed in claim 1, wherein the monoclonal antibody is bound to human bFGF containing the amino acid sequence: Phe-Phe-Leu-Arg-Ile-His-Pro-Asp-Gly-Arg-Val-Asp-Gly-Val-Arg-Glu-Lys-Ser-Asp-Pro.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.